用于全身给药的聚乙二醇化纳米载体。
PEGylated nanocarriers for systemic delivery.
作者信息
Jain N K, Nahar Manoj
机构信息
Department of Pharmaceutical Sciences, Dr. H.S.Gour University, Sagar, India.
出版信息
Methods Mol Biol. 2010;624:221-34. doi: 10.1007/978-1-60761-609-2_15.
In this chapter, we outline the protocols for PEGylation of some drug carriers, such as dendrimer, polymeric nanoparticles, liposomes, for systemic delivery. PEGylation simply refers to the modification of particle surface by covalently grafting, entrapping, or adsorbing PEG chains of vivid length. However, limitation of simple adsorption being easy displacement of the coating layer in vivo, covalent mode for PEGylation of nanoparticles is mostly preferred, and outlined herein. Derivatization and activation of polyethylene glycol is an important step during PEGylation and its chemistry chiefly relies on availability as well as type of functional groups on carrier periphery. A summarized set of protocols for PEGylation of widely explored nanocarriers for systemic delivery is presented.
在本章中,我们概述了一些用于全身给药的药物载体(如树枝状大分子、聚合物纳米颗粒、脂质体)的聚乙二醇化方案。聚乙二醇化简单来说就是通过共价接枝、包封或吸附不同长度的聚乙二醇链来修饰颗粒表面。然而,简单吸附存在体内涂层易被置换的局限性,因此纳米颗粒的聚乙二醇化大多采用共价模式,本文对此进行了概述。聚乙二醇的衍生化和活化是聚乙二醇化过程中的重要步骤,其化学反应主要取决于载体周边官能团的可用性和类型。本文给出了一套用于广泛研究的全身给药纳米载体聚乙二醇化的方案总结。